Skip to main content
. 2021 May 25;14(6):504. doi: 10.3390/ph14060504

Table 2.

Summary of the studies involving myo-inositol as a pretreatment for women undergoing IVF.

Study Patients Protocol Findings
Lisi et al. 2012 [31] 100 non-PCOS women with basal FSH <10 mUI/mL Randomized, controlled treatment with 2000 mg twice a day for 3 months Exogenous FSH required to reach follicular maturation: 2.084 UI in the treatment group versus 2.479 UI in the control group
Caprio et al. 2015 [32] 76 non-PCOS infertile women Controlled treatment with 4000 mg/day for 3 months Percentage of metaphase II oocytes: 80.5% in the treatment group versus 66.6% in the control group
Ovarian sensitivity index: 1.88 ± 0.81 in the treatment group versus 1.54 ± 0.65 in the control group